CN Patent

CN103298451B — 溴莫尼定凝胶剂组合物及其使用方法

Assigned to Galderma SA · Expires 2016-04-20 · 10y expired

What this patent protects

本发明描述了改进的外用凝胶剂组合物，如含有用于皮肤病治疗的溴莫尼定的外用凝胶剂组合物。所述凝胶剂组合物含有卡波姆和对羟基苯甲酸甲酯，且长时间贮存后基本没有对羟基苯甲酸甲酯晶体颗粒。

USPTO Abstract

本发明描述了改进的外用凝胶剂组合物，如含有用于皮肤病治疗的溴莫尼定的外用凝胶剂组合物。所述凝胶剂组合物含有卡波姆和对羟基苯甲酸甲酯，且长时间贮存后基本没有对羟基苯甲酸甲酯晶体颗粒。

Drugs covered by this patent

Patent Metadata

Patent number
CN103298451B
Jurisdiction
CN
Classification
—
Expires
2016-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Galderma SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.